{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:15:23Z","timestamp":1792091723005,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002674","name":"Russian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejpb.2024.114531","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T06:25:18Z","timestamp":1728887118000},"page":"114531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Unleashing the antitumor power of cyclophosphamide by arabinogalactan and aptamer conjugation"],"prefix":"10.1016","volume":"204","author":[{"given":"Tatiana N.","family":"Zamay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga S.","family":"Kolovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina S.","family":"Zamay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey K.","family":"Kirichenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia A.","family":"Luzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey S.","family":"Zamay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda A.","family":"Neverova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N.","family":"Medvedeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilii A.","family":"Babkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Veprintsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Shchugoreva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-4629","authenticated-orcid":false,"given":"Anna S.","family":"Kichkailo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2024.114531_b0005","first-page":"69","article-title":"Decreased cytotoxicity of cisplatin by conjugation with arabinogalactan","volume":"37","author":"Zamay","year":"2020","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.ejpb.2024.114531_b0010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1958","article-title":"Polymer conjugates as anticancer nanomedicines","volume":"6","author":"Dunkan","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114531_b0015","first-page":"200","article-title":"Polymer-drug conjugates: recent achievements","volume":"2","author":"Gaikwad","year":"2011","journal-title":"Res. J. Pharm., Bio. Chem. Sci."},{"key":"10.1016\/j.ejpb.2024.114531_b0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/10010114","article-title":"Covalent polymer-drug conjugates","volume":"10","author":"Elvira","year":"2005","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ejpb.2024.114531_b0025","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s11010-023-04805-0","article-title":"Molecular mechanisms underlying cyclophosphamide-induced cognitive impairment and strategies for neuroprotection in preclinical models","volume":"479","author":"Ibrahim","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejpb.2024.114531_b0030","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.biopha.2017.01.072","article-title":"Combination of arabinogalactan and curcumin induces apoptosis in breast cancer cells in vitro and inhibits tumor growth via overexpression of p53 level in vivo","volume":"88","author":"Moghtaderi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2024.114531_b0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejpb.2015.04.001","article-title":"Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: mechanistic insights and interactome analysis","volume":"93","author":"Joseph","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114531_b0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.intimp.2019.05.025","article-title":"Immunostimulatory plant polysaccharides impede cancer progression and metastasis by avoiding off-target effects","volume":"73","author":"Varghese","year":"2019","journal-title":"Int. Immunopharmacology"},{"key":"10.1016\/j.ejpb.2024.114531_b0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/14740338.6.2.183","article-title":"The safety profile of cyclophosphamide in multiple sclerosis therapy","volume":"6","author":"Perini","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114531_b0050","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/rheumatology\/kev196","article-title":"The evolving paradigm of cancer risk related to cyclophosphamide therapy in granulomatosis with polyangiitis","volume":"54","author":"Calatroni","year":"2015","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114531_b0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/scipharm88040042","article-title":"The mechanism of action of cyclophosphamide and its consequences for the development of a new generation of oxazaphosphorine cytostatics","volume":"88","author":"Voelcker","year":"2020","journal-title":"Scientia pharmaceutica"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114531_b0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.bmt.1704763","article-title":"Cardiac toxicity of high-dose chemotherapy","volume":"35","author":"Morandi","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejpb.2024.114531_b0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.micres.2014.11.002","article-title":"Effects of cyclophosphamide on immune system and gut microbiota in mice","volume":"171","author":"Xu","year":"2015","journal-title":"Microbiol. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114531_b0070","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/bm8014973","article-title":"Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications","volume":"10","author":"Santo","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2024.114531_b0075","doi-asserted-by":"crossref","unstructured":"Chapman V.J., Capman D.J. Seaweeds and their uses.1980, London-New York: and Hall., 334.","DOI":"10.1007\/978-94-009-5806-7"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114531_b0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.phrs.2005.09.009","article-title":"Effect of low molecular \u03bb-carrageenan from Chondrus ocellatus on antitumor H-22 activity of 5-Fu","volume":"53","author":"Zhou","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejpb.2024.114531_b0085","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/bm900853z","article-title":"Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells","volume":"11","author":"Pinhassi","year":"2010","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114531_b0090","first-page":"96","article-title":"Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide","volume":"4","author":"Kelly","year":"1999","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.ejpb.2024.114531_b0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/10717544.2016.1225856","article-title":"Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma","volume":"24","author":"Pranatharthiharan","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114531_b0100","unstructured":"Domb A., Polacheck I., Soskolni M., Golenser J. Conjugates of therapeutically active compounds. 2007, Patent 2007\/034495 (WO)."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114531_b0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1773-2247(13)50062-1","article-title":"Intracellular disposition of arabinogalactan and asialofetuin in HepG2 cells","volume":"23","author":"Tanaka","year":"2013","journal-title":"J. Drug Deliv. Sci. Tech."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114531_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40824-023-00365-y","article-title":"Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery","volume":"27","author":"Narwade","year":"2023","journal-title":"Biomater. Res."},{"key":"10.1016\/j.ejpb.2024.114531_b0115","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1039\/C5AN00954E","article-title":"Trends in aptamer selection methods and applications","volume":"140","author":"Y\u00fcce","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.ejpb.2024.114531_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13036-019-0223-y","article-title":"SELEX tool: a novel and convenient gel-based diffusion method for monitoring of aptamer-target binding","volume":"14","author":"Liu","year":"2020","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.ejpb.2024.114531_b0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1134\/S1990747813050061","article-title":"DNA-aptamer\/protein interaction as a cause of apoptosis and arrest of proliferation in Ehrlich ascites adenocarcinoma cells","volume":"8","author":"Kolovskaya","year":"2014","journal-title":"Biochem. (Moscow) Supplement Series A: Membrane and Cell Biology"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114531_b0130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijbiomac.2009.06.012","article-title":"Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue","volume":"45","author":"McDowell","year":"2009","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2024.114531_b0135","doi-asserted-by":"crossref","unstructured":"Cyran A.M., Zhitkovich A. Heat Shock Proteins and HSF1 in Cancer. 2022, Front. Oncol., 12, 860320.","DOI":"10.3389\/fonc.2022.860320"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114531_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jfb14040179","article-title":"Magnetic nanoscalpel for the effective treatment of ascites tumors","volume":"14","author":"Zamay","year":"2023","journal-title":"J. Functional Biomater."},{"key":"10.1016\/j.ejpb.2024.114531_b0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.omtn.2017.08.007","article-title":"Aptamer-targeted plasmonic phototermal therapy of cancer","volume":"9","author":"Kolovskaya","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.ejpb.2024.114531_b0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/nat.2022.0024","article-title":"Nucleic acid aptamers increase the anticancer efficiency and reduce the toxicity of cisplatin-arabinogalactan conjugates in vivo","volume":"32","author":"Zamay","year":"2022","journal-title":"Nucleic Acid Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114531_b0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/cancers12010216","article-title":"Aptamer-conjugated superparamagnetic ferroarabinogalactan nanoparticles for targeted magnetodynamic therapy of cancer","volume":"12","author":"Kolovskaya","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejpb.2024.114531_b0160","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1134\/S1068162019070082","article-title":"Synthesis and investigation of the physicochemical properties of mechanocomposites of arabinogalactan with cyclophosphamide","volume":"45","author":"Neverova","year":"2019","journal-title":"Russian J. Bioorganic Chem."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114531_b0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3727\/095535491820873191","article-title":"Use of an Aqueous Soluble Tetrazolium\/Formazan Assay for Cell Growth Assays in Culture","volume":"3","author":"Cory","year":"1991","journal-title":"Cancer Commun."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114531_b0170","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s11172-008-0167-8","article-title":"Mechanochemical preparation and pharmacological activities of water-soluble intermolecular complexes of arabinogalactan with medicinal agents","volume":"57","author":"Dushkin","year":"2008","journal-title":"Russ. Chem. Bull."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114531_b0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jcc.20496","article-title":"Pair interaction energy decomposition analysis","volume":"28","author":"Fedorov","year":"2007","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114531_b0180","first-page":"3274","article-title":"Mechanism of cyclophosphamide transport by L5178Y lymphoblasts in vitro","volume":"34","author":"Goldenberg","year":"1974","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114531_b0185","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/nat.2013.0471","article-title":"DNA-aptamer targeting vimentin for tumor therapy in vivo","volume":"23","author":"Zamay","year":"2014","journal-title":"Nucleic Acid Therapeutics"},{"key":"10.1016\/j.ejpb.2024.114531_b0190","doi-asserted-by":"crossref","unstructured":"Harris R.L., van den Berg C.W., Bowen D.J. ASGR1 and ASGR2, the genes that encode the asialoglycoprotein receptor (ashwell receptor), are expressed in peripheral blood monocytes and show interindividual differences in transcript profile. 2012, Mol. Biol. Int., 2012:283974.","DOI":"10.1155\/2012\/283974"},{"key":"10.1016\/j.ejpb.2024.114531_b0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications","volume":"203","author":"D'Souza","year":"2015","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114531_b0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1748-1716.2006.01562.x","article-title":"On the mechanism of ionic regulation of apoptosis: would the Na+\/K+-ATPase please stand up?","volume":"187","author":"Panayiotidis","year":"2006","journal-title":"Acta physiologica"},{"key":"10.1016\/j.ejpb.2024.114531_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.715492","article-title":"Low-dose cyclophosphamide induces nerve injury and functional overactivity in the urinary bladder of rats","volume":"15","author":"Wang","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114531_b0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10600-014-0918-8","article-title":"Mechanical composites of rimantadine and larch arabinogalactan","volume":"50","author":"Babkin","year":"2014","journal-title":"Chem. Nat. Compounds"},{"key":"10.1016\/j.ejpb.2024.114531_b0220","unstructured":"Dushkin A.V., Tolstikova T.G., Khostov M.V., Tolstikov G.A. Complexes of polysaccharides and glycyrrhizic acid with drug molecules. Mechanochemical synthesis and pharmacological activity. 2012, in book The Complex World of Polysaccharides, ed. By Dr. D.N. Karunaratn. Publisher In Tech, 573-602."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114531_b0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1158\/2326-6066.CIR-16-0048","article-title":"Old-school chemotherapy in immunotherapeutic combination in cancer, a low-cost drug repurposed","volume":"4","author":"Eid","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ejpb.2024.114531_b0230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","article-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision","volume":"218","author":"Iqubal","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114531_b0235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12986-016-0086-x","article-title":"Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials","volume":"13","author":"Dion","year":"2016","journal-title":"Nut. Metabolism"},{"issue":"5","key":"10.1016\/j.ejpb.2024.114531_b0240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/07315724.2013.839907","article-title":"Immunomodulatory effects of ResistAid: a randomized, double-blind, placebo-controlled, multidose study","volume":"32","author":"Udani","year":"2013","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.ejpb.2024.114531_b0245","unstructured":"Nantz M., Painter A., Parker E., McGill C., Percival S. Evaluation of arabinogalactan\u2019s effect on human immunity. 2001, FASEB J., 15(4), 633."},{"key":"10.1016\/j.ejpb.2024.114531_b0250","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01740905","article-title":"Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis","volume":"36","author":"Hauer","year":"1993","journal-title":"Cancer Immunol., Immunotherapy"},{"issue":"19","key":"10.1016\/j.ejpb.2024.114531_b0255","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1016\/S0021-9258(19)70522-5","article-title":"Difficulties in the quantification of asialoglycoprotein receptors on the rat hepatocyte","volume":"255","author":"Schwartz","year":"1980","journal-title":"J. Bio. Chem."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114531_b0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3346\/jkms.1997.12.3.185","article-title":"The effect of cyclophosphamide on Fas-mediated apoptosis","volume":"12","author":"Lee","year":"1997","journal-title":"J. Korean Med. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114531_b0265","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1254\/jphs.08173FP","article-title":"Anil Kumar Balapure, and Srikanta Kumar Rath. \u201cCaspase mediated enhanced apoptotic action of cyclophosphamide-and resveratrol-treated MCF-7 cells.\u201d","volume":"109","author":"Singh","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114531_b0270","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/1061186X.2018.1491978","article-title":"Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles","volume":"27","author":"Zununi Vahed","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2024.114531_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.715492","article-title":"Low-dose cyclophosphamide induces nerve injury and functional overactivity in the urinary bladder of rats","volume":"15","author":"Wang","year":"2021","journal-title":"Front. Neurosci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124003576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124003576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T19:30:12Z","timestamp":1730143812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124003576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":54,"alternative-id":["S0939641124003576"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114531","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unleashing the antitumor power of cyclophosphamide by arabinogalactan and aptamer conjugation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114531"}}